143 related articles for article (PubMed ID: 38740611)
1. Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment.
Gebert P; Hage AM; Blohmer JU; Roehle R; Karsten MM
Support Care Cancer; 2024 May; 32(6):344. PubMed ID: 38740611
[TBL] [Abstract][Full Text] [Related]
2. Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients.
Karsten MM; Roehle R; Albers S; Pross T; Hage AM; Weiler K; Fischer F; Rose M; Kühn F; Blohmer JU
Eur J Cancer; 2022 Mar; 163():128-139. PubMed ID: 35066338
[TBL] [Abstract][Full Text] [Related]
3. Satisfaction with care and adherence to treatment when using patient reported outcomes to individualize follow-up care for women with early breast cancer - a pilot randomized controlled trial.
Riis CL; Jensen PT; Bechmann T; Möller S; Coulter A; Steffensen KD
Acta Oncol; 2020 Apr; 59(4):444-452. PubMed ID: 32000559
[No Abstract] [Full Text] [Related]
4. Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy - a feasibility study.
Taarnhøj GA; Lindberg H; Dohn LH; Omland LH; Hjøllund NH; Johansen C; Pappot H
Health Qual Life Outcomes; 2020 Jul; 18(1):225. PubMed ID: 32653005
[TBL] [Abstract][Full Text] [Related]
5. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.
Partridge A; Adloff K; Blood E; Dees EC; Kaelin C; Golshan M; Ligibel J; de Moor JS; Weeks J; Emmons K; Winer E
J Natl Cancer Inst; 2008 Feb; 100(4):243-51. PubMed ID: 18270338
[TBL] [Abstract][Full Text] [Related]
6. Data of real-world reference scores for EORTC QLQ-C30 and QLQ-BR23 at baseline in women with early breast cancer and other breast diseases.
Gebert P; Dordevic AD; Roehle R; Hage AM; Karsten MM
Data Brief; 2022 Aug; 43():108347. PubMed ID: 35720770
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen Acceptance and Adherence among Patients with Ductal Carcinoma In Situ (DCIS) Treated in a Multidisciplinary Setting.
Karavites LC; Kane AK; Zaveri S; Xu Y; Helenowski I; Hansen N; Bethke KP; Rasmussen-Torvik LJ; Khan SA
Cancer Prev Res (Phila); 2017 Jul; 10(7):389-397. PubMed ID: 28559459
[TBL] [Abstract][Full Text] [Related]
8. Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer.
Lauzier S; Maunsell E; Levesque P; Mondor M; Robert J; Robidoux A; Provencher L
Breast Cancer Res Treat; 2010 Apr; 120(3):685-91. PubMed ID: 19653097
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
10. Adherence to the World Cancer Research Fund/American Institute for Cancer Research Guideline Is Associated With Better Health-Related Quality of Life Among Chinese Patients With Breast Cancer.
Lei YY; Ho SC; Cheng A; Kwok C; Lee CI; Cheung KL; Lee R; Loong HHF; He YQ; Yeo W
J Natl Compr Canc Netw; 2018 Mar; 16(3):275-285. PubMed ID: 29523666
[No Abstract] [Full Text] [Related]
11. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
12. Trends in Health-Related Quality of Life After a Diagnosis of Ductal Carcinoma In Situ.
Hart V; Sprague BL; Lakoski SG; Hampton JM; Newcomb PA; Gangnon RE; Trentham-Dietz A
J Clin Oncol; 2016 Apr; 34(12):1323-9. PubMed ID: 26884560
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial.
Vrieling C; van Werkhoven E; Maingon P; Poortmans P; Weltens C; Fourquet A; Schinagl D; Oei B; Rodenhuis CC; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan DA; Dubois JB; Remouchamps V; Mirimanoff RO; Hart G; Collette S; Collette L; Bartelink H;
JAMA Oncol; 2017 Jan; 3(1):42-48. PubMed ID: 27607734
[TBL] [Abstract][Full Text] [Related]
15. Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls.
Jeffe DB; Pérez M; Liu Y; Collins KK; Aft RL; Schootman M
Breast Cancer Res Treat; 2012 Jul; 134(1):379-91. PubMed ID: 22484800
[TBL] [Abstract][Full Text] [Related]
16. Psychosexual functioning and body image following a diagnosis of ductal carcinoma in situ.
Bober SL; Giobbie-Hurder A; Emmons KM; Winer E; Partridge A
J Sex Med; 2013 Feb; 10(2):370-7. PubMed ID: 22812628
[TBL] [Abstract][Full Text] [Related]
17. Impact of the COVID-19 Pandemic on Patient-Reported Outcomes of Breast Cancer Patients and Survivors.
Bargon CA; Batenburg MCT; van Stam LE; Mink van der Molen DR; van Dam IE; van der Leij F; Baas IO; Ernst MF; Maarse W; Vermulst N; Schoenmaeckers EJP; van Dalen T; Bijlsma RM; Young-Afat DA; Doeksen A; Verkooijen HM
JNCI Cancer Spectr; 2021 Feb; 5(1):pkaa104. PubMed ID: 33437925
[TBL] [Abstract][Full Text] [Related]
18. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
[TBL] [Abstract][Full Text] [Related]
19. The psychosocial impact of ductal carcinoma in situ (DCIS): a longitudinal prospective study.
Kennedy F; Harcourt D; Rumsey N; White P
Breast; 2010 Oct; 19(5):382-7. PubMed ID: 20413310
[TBL] [Abstract][Full Text] [Related]
20. What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?
Mercieca-Bebber R; King MT; Boxer MM; Spillane A; Winters ZE; Butow PN; McPherson J; Rutherford C
Breast Cancer; 2017 Sep; 24(5):720-729. PubMed ID: 28247220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
